Pan‐cancer analysis of prognostic metastatic phenotypes

Author:

Zaorsky Nicholas G.12ORCID,Wang Xi2,Garrett Sara M.12ORCID,Lehrer Eric J.3,Lin Christine12,DeGraff David J.4,Spratt Daniel E.5,Trifiletti Daniel M.6,Kishan Amar U.7,Showalter Timothy N.8,Park Henry S.9,Yang Jonathan T.10,Chinchilli Vernon M.2,Wang Ming2

Affiliation:

1. Department of Radiation Oncology Penn State Cancer Institute Hershey Pennsylvania USA

2. Department of Public Health Sciences Penn State College of Medicine Hershey Pennsylvania USA

3. Department of Radiation Oncology Icahn School of Medicine at Mount Sinai New York New York USA

4. Division of Experimental Pathology, Department of Pathology and Laboratory Medicine Penn State College of Medicine Hershey Pennsylvania USA

5. Department of Radiation Oncology University Hospitals Seidman Cancer Center, Case Western Reserve University Cleveland OH USA

6. Department of Radiation Oncology Mayo Clinic Jacksonville Jacksonville Florida USA

7. Department of Radiation Oncology University of California, Los Angeles Los Angeles California USA

8. Department of Radiation Oncology University of Virginia Charlottesville Virginia USA

9. Department of Therapeutic Radiology Yale School of Medicine New Haven Connecticut USA

10. Department of Radiation Oncology Memorial Sloan Kettering Cancer Center New York New York USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Cancer statistics, 2017

2. KolataG.‘Desperation oncology’: when patients are dying some cancer doctors turn to immunotherapy.New York Times.2018; Section D Page 1.https://www.nytimes.com/2018/04/26/health/doctors-cancer-immunotherapy.html

3. End-of-Life Care for Hospitalized Patients with Lung Cancer: Utilization of a Palliative Care Service

4. Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3